Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool - 28/11/19

Mike Sharland ^a, Sumanth Gandra ^b, Benedikt Huttner ^e, Lorenzo Moja ^g, Celine Pulcini ^c, Mei Zeng ^d, Marc Mendelson ^f, Bernadette Cappello ^g, Graham Cooke ^h, Nicola Magrini ^g
on behalf of the

EML Expert Committee and Antibiotic Working Group

Zeba Aziz, Franco Cavalli, Elisabeth De Vries, Armando Genazzani, Monica Imi, Gregory Kearns, Gilbert Kokwaro, Gabriela J Prutsky, Nizal Sarrafzadegan, Shalini Sri Ranganathan, Fatima Suleman, Worasuda Yoongthong, Stephan Harbarth, Mark Loeb, Dominik Mertz, Evelina Tacconelli, Maria V Villegas

^a Paediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St George’s University of London, London, UK 

^b Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO, USA 

^c Department of Infectious Diseases and APEMAC, Université de Lorraine, Université de Lorraine, Nancy, France 

^d Department of Infectious Diseases, Children’s Hospital of Fudan University, Shanghai, China 

^e Division of Infectious Diseases, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland 

^f Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa 

^g Department of Essential Medicines and Health Products, World Health Organization, Geneva 1211, Switzerland 

^h Department of Infectious Disease, Imperial College London, London, UK 

Le texte complet de cet article est disponible en PDF.